Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Kengo Hasui"'
Autor:
Junichi Nakagawa, Takenori Takahata, Rui Hyodo, Yu Chen, Kengo Hasui, Kota Sasaki, Kensuke Saito, Kayo Ueno, Kazuhiro Hosoi, Kazufumi Terui, Atsushi Sato, Takenori Niioka
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Abstract (R-)miniCHOP therapy, which delivers approximately half-doses of the (R-)CHOP regimen, has shown efficacy and safety in patients who are more than 80 years old. This study aimed to compare the area under the plasma concentration–time curve
Externí odkaz:
https://doaj.org/article/1d497b016aaa46f099d7aeea7dbe6d5f
Autor:
Kota Sasaki, Yusuke Yokota, Toshihito Isojima, Mayumi Fujii, Kengo Hasui, Yu Chen, Kensuke Saito, Takenori Takahata, Seiko Kindaichi, Atsushi Sato
Publikováno v:
Respirology Case Reports, Vol 9, Iss 7, Pp n/a-n/a (2021)
Abstract Alectinib treatment is effective in patients with anaplastic lymphoma kinase (ALK) gene rearrangement‐positive non‐small cell lung cancer (NSCLC; hereafter ALK‐positive NSCLC) who exhibit central nervous system (CNS) relapse and poor p
Externí odkaz:
https://doaj.org/article/3af057e1f9cc42eaaddb14c9a27b799d
Autor:
Naomi Kudo, Akira Kurose, Ryutaro Hara, Junko Takahata, Kengo Hasui, Atsushi Sato, Atsushi Matsubara
Publikováno v:
Human Pathology: Case Reports, Vol 24, Iss , Pp 200508- (2021)
SMARCA4-deficient thoracic tumor (SMARCA4-DTT) is a relatively new pathological entity with highly aggressive characteristics. With mass lesions developing in the thoracic region, patients tend to complain of chest symptoms, such as dyspnea or chest
Externí odkaz:
https://doaj.org/article/d90e9c0520f24d6a84478d35d3a41f1a
Autor:
Atsushi Sato, Yusuke Yokota, Kensuke Saito, Yu Chen, Kengo Hasui, Kota Sasaki, Toshihito Isojima, Mayumi Fujii, Takenori Takahata, Seiko Kindaichi
Publikováno v:
Respirology Case Reports
Respirology Case Reports, Vol 9, Iss 7, Pp n/a-n/a (2021)
Respirology Case Reports, Vol 9, Iss 7, Pp n/a-n/a (2021)
Alectinib treatment is effective in patients with anaplastic lymphoma kinase (ALK) gene rearrangement‐positive non‐small cell lung cancer (NSCLC; hereafter ALK‐positive NSCLC) who exhibit central nervous system (CNS) relapse and poor performanc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::106f6eacb53267f81b4c01d0b1935a26
https://doi.org/10.1002/rcr2.796
https://doi.org/10.1002/rcr2.796
Autor:
Atsushi Sato, Junko Takahata, Ryutaro Hara, Akira Kurose, Kengo Hasui, Atsushi Matsubara, Naomi Kudo
Publikováno v:
Human Pathology: Case Reports, Vol 24, Iss, Pp 200508-(2021)
SMARCA4-deficient thoracic tumor (SMARCA4-DTT) is a relatively new pathological entity with highly aggressive characteristics. With mass lesions developing in the thoracic region, patients tend to complain of chest symptoms, such as dyspnea or chest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30694f3b6811046944363bbef95de48e
http://www.sciencedirect.com/science/article/pii/S2214330021000377
http://www.sciencedirect.com/science/article/pii/S2214330021000377
Purpose: Malnutrition increases chemotherapy toxicity and impairs quality of life. Previous studies have shown an association between nutrition assessment tools, such as the Geriatric Nutrition Risk Index (GNRI), and adverse events of chemotherapy. H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a34dba9824e50ab14c5eb68c987039b
https://doi.org/10.21203/rs.3.rs-236105/v1
https://doi.org/10.21203/rs.3.rs-236105/v1
Autor:
Rina Watanabe, Kengo Hasui, Atsushi Sato, Takenori Takahata, Kensuke Saito, Shinsaku Fukuda, Hiroto Hiraga, Yu Chen, Keisuke Hasui, Kota Sasaki, Hirotake Sakuraba
Publikováno v:
Annals of Oncology. 32:S336
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ba52e93be029c4ec3d7ad2d63dfd50b
https://doi.org/10.1016/j.annonc.2021.05.695
https://doi.org/10.1016/j.annonc.2021.05.695
Autor:
Yu Chen, Akemi Awatsu, Kengo Hasui, Emiko Abo, Atsushi Sato, Takenori Takahata, Kensuke Saito
Publikováno v:
Annals of Oncology. 30:vi121
Introduction Malignant lymphoma is a curable disease by chemotherapy, and therefore very elderly patients with good condition can undergo reduced-dose chemotherapy and achieve longer survival. But there are few studies about those who are frail and c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::afd2b156e908e33d4181727a06b96f36
https://doi.org/10.1093/annonc/mdz343.015
https://doi.org/10.1093/annonc/mdz343.015